Nandrolone Decanoate Injection — Class II drug recall D-397-2013
Terminated recall by FVS Holdings, Inc. dba. Green Valley Drugs, reported 2013-05-22, distributed nationwide. Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compoundi
| Recall number | D-397-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | FVS Holdings, Inc. dba. Green Valley Drugs, Henderson, NV, United States |
| Recall initiated | 2013-04-10 |
| Classified | 2013-05-16 |
| Reported by FDA | 2013-05-22 |
| Terminated | 2014-03-21 |
| Distributed | Nationwide (US) |
| Quantity | 43 vials |
| Reason classes | sterility |
| Expiration dates | 2013-06-11 |
Product
Nandrolone Decanoate Injection, all strengths and all presentations including a) Nandrolone Decanoate 300 mg/mL, b) Nandrolone 200 mg/mL, c) Nandrolone 250 mg/mL, d) Nandrolone 350 mg/mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.
Reason for recall
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-397-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.